Groupama Asset Management’s Repligen RGEN Stock Holding History

Groupama Asset Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	7,938 +371	+5%	+$45.6K	0.01%	218
2026 Q1	$892K	Buy	7,567 +130	+2%	+$18.2K	0.01%	224
2025 Q4	$1.22M	Buy	7,437 +5,903	+385%	+$925K	0.02%	221
2025 Q3	$610K	Sell	1,534 -3,656	-70%	-$444K	0.01%	323
2025 Q2	$1.04M	Hold	5,190	–	–	0.02%	272
2025 Q1	$1.1M	Buy	5,190 +1,258	+32%	+$194K	0.02%	241
2024 Q4	$976K	Buy	3,932 +680	+21%	+$97.5K	0.02%	276
2024 Q3	$389K	Hold	3,252	–	–	0.01%	366
2024 Q2	$410K	Hold	3,252	–	–	0.01%	383
2024 Q1	$598K	Buy	3,252 +758	+30%	+$144K	0.01%	367
2023 Q4	$449K	Buy	+2,494	New	+$388K	0.01%	346

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Groupama Asset Management's RGEN Position: Q2 2026 in Review

Groupama Asset Management increased its Repligen (RGEN) stake by 4.9% in Q2 2026, buying an estimated $45.6K and bringing the position to 7,938 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #218.

Groupama Asset Management first reported a position in RGEN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.22M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Groupama Asset Management held 7,938 shares of Repligen worth $1.09M as of Q2 2026.
Groupama Asset Management bought 371 Repligen shares in Q2 2026, an estimated $45.6K.
Repligen made up 0.01% of Groupama Asset Management's portfolio in Q2 2026, its #218 holding.
Groupama Asset Management first reported a position in Repligen in Q4 2023 and has held it in 11 quarters since.
Groupama Asset Management's Repligen position peaked at $1.22M in Q4 2025.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.